The primary aim of this project is to establish the acceptability of the PAI (physical activity intervention) to service users by evaluating if participants can be recruited into the study and if they complete the intervention. Secondary aims are to estimate if, compared with treatment as usual (TAU), the PAI intervention (1) positively impacts on subjects' psychiatric symptoms (2) succeeds in improving cardiovascular fitness performance. In addition, will be considered the impact of the PAI versus TAU on sleep behavior, quality of life, drug consumption, reduces sedentary behaviour and unscheduled readmissions to the department within 30 days and within 7 days after their dismission.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
80
Physical activity
Percentage of patients that will complete the study (Acceptability)
to evaluate if participants can be recruited into the study and if they complete the intervention.
Time frame: 24-26 weeks
Anthropometric measures
Body Max Index (BMI), in kg/m\^2
Time frame: 24-26 weeks
Anthropometric measures
height in centimeters
Time frame: 24-26 weeks
Anthropometric measures
abdominal circumference in centimeters
Time frame: 24-26 weeks
Anthropometric measures
weight in kilograms
Time frame: 24-26 weeks
Self-report sedentary behaviour and physical activity
International Physical Activity Questionnaire (IPAQ)
Time frame: 24-26 weeks
Cardiorespiratory Fitness
6MWT
Time frame: 24-26 weeks
Sleep behavior
Pittsburgh sleep quality index (PSQI)
Time frame: 24-26 weeks
Quality of life (QoL)
The Quality of Life Enjoyment and Satisfaction Questionnaire - Short Form (Q-LES-Q-SF)
Time frame: 24-26 weeks
Motivation to engage in physical activity
Behavioral Regulation in Exercise Questionnaire-2 (BREQ-2)
Time frame: 24-26 weeks
Psychiatric symptoms
brief psychiatric rating scale (BPRS)
Time frame: 24-26 weeks
Psychiatric symptoms
Hamilton Depression Rating Scale (HAM-D)
Time frame: 24-26 weeks
Blood samples
HIgh Density Lipoproteins (HDL)
Time frame: 24-26 weeks
Blood samples
blood glucose levels
Time frame: 24-26 weeks
Blood samples
insulin levels
Time frame: 24-26 weeks
Blood samples
triglycerides
Time frame: 24-26 weeks
Blood samples
C-reactive Protein (CRP)
Time frame: 24-26 weeks
Blood samples
Low Density Lipoproteins (LDP)
Time frame: 24-26 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.